Dong Ren

3.7k total citations
57 papers, 2.7k citations indexed

About

Dong Ren is a scholar working on Molecular Biology, Cancer Research and Oncology. According to data from OpenAlex, Dong Ren has authored 57 papers receiving a total of 2.7k indexed citations (citations by other indexed papers that have themselves been cited), including 32 papers in Molecular Biology, 30 papers in Cancer Research and 14 papers in Oncology. Recurrent topics in Dong Ren's work include MicroRNA in disease regulation (20 papers), Cancer-related molecular mechanisms research (15 papers) and Circular RNAs in diseases (10 papers). Dong Ren is often cited by papers focused on MicroRNA in disease regulation (20 papers), Cancer-related molecular mechanisms research (15 papers) and Circular RNAs in diseases (10 papers). Dong Ren collaborates with scholars based in China, United States and Australia. Dong Ren's co-authors include Xinsheng Peng, Shuai Huang, Wei Guo, Libing Song, Hong Du, Xin Zhang, Yuhu Dai, Xuenong Zou, Qing Yang and Yubo Tang and has published in prestigious journals such as The Journal of Experimental Medicine, SHILAP Revista de lepidopterología and PLoS ONE.

In The Last Decade

Dong Ren

55 papers receiving 2.7k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Dong Ren China 33 2.0k 1.7k 619 436 203 57 2.7k
Chuyong Lin China 33 2.0k 1.0× 1.3k 0.8× 630 1.0× 333 0.8× 313 1.5× 60 2.8k
Paolo Gandellini Italy 31 2.2k 1.1× 1.7k 1.0× 527 0.9× 358 0.8× 124 0.6× 62 2.9k
Altaf A. Dar United States 27 2.0k 1.0× 1.2k 0.7× 622 1.0× 239 0.5× 325 1.6× 51 2.5k
Yixuan Hou China 26 1.8k 0.9× 1.4k 0.8× 765 1.2× 218 0.5× 165 0.8× 38 2.5k
Jongchan Kim United States 18 1.8k 0.9× 1.4k 0.8× 435 0.7× 822 1.9× 149 0.7× 34 2.5k
Aleksandra Franovic United States 18 1.3k 0.6× 744 0.4× 600 1.0× 336 0.8× 289 1.4× 38 2.0k
Douglas S. Micalizzi United States 14 1.6k 0.8× 841 0.5× 1.2k 1.9× 293 0.7× 206 1.0× 25 2.4k
Bisrat G. Debeb United States 28 1.3k 0.7× 810 0.5× 1.1k 1.8× 310 0.7× 144 0.7× 61 2.3k
Zhengsheng Wu China 27 1.5k 0.7× 953 0.6× 683 1.1× 185 0.4× 240 1.2× 69 2.3k
Weijian Guo China 19 1.4k 0.7× 647 0.4× 482 0.8× 271 0.6× 89 0.4× 57 1.9k

Countries citing papers authored by Dong Ren

Since Specialization
Citations

This map shows the geographic impact of Dong Ren's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Dong Ren with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Dong Ren more than expected).

Fields of papers citing papers by Dong Ren

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Dong Ren. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Dong Ren. The network helps show where Dong Ren may publish in the future.

Co-authorship network of co-authors of Dong Ren

This figure shows the co-authorship network connecting the top 25 collaborators of Dong Ren. A scholar is included among the top collaborators of Dong Ren based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Dong Ren. Dong Ren is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
3.
Ren, Dong, Li Zhang, Shan Liu, et al.. (2024). Therapeutic SHPRH-146aa encoded by circ-SHPRH dynamically upregulates P21 to inhibit CDKs in neuroblastoma. Cancer Letters. 598. 217120–217120. 7 indexed citations
4.
Jiang, Xiaomei, Xuhui Zhang, Dong Ren, et al.. (2024). Assessing the impact of diverse mask types on COPD patients: a randomised controlled trial study protocol. BMJ Open. 14(1). e080721–e080721. 1 indexed citations
5.
Ren, Dong, Yanfeng Zhang, Xiaojing Ma, et al.. (2024). Effects of acupuncture and nicotine patch on smoking: a multicenter, randomized, controlled, double-blind clinical trial. Frontiers in Medicine. 11. 1418967–1418967. 1 indexed citations
6.
Ren, Dong, et al.. (2024). Primary Adenosquamous Carcinoma of the Prostate. Diagnostics. 14(6). 645–645.
7.
Zhang, Yan, Yong Zhang, Lingling Wang, et al.. (2023). Effect of MBSR, DBT and CBT on the hypertension patients with depression/anxiety: Protocol of a systematic review and Bayesian network meta-analysis. PLoS ONE. 18(2). e0281469–e0281469. 1 indexed citations
8.
9.
Wang, Chunyan, Xueyun Duan, Xiaojun Guo, et al.. (2023). Comparison of the conventional tube and erythrocyte-magnetized technology in titration of red blood cell alloantibodies. World Journal of Biological Chemistry. 14(3). 62–71. 1 indexed citations
10.
Wu, Xianqiu, Bin Wang, Yaorong Su, et al.. (2022). ALG8 Fuels Stemness Through Glycosylation of the WNT/Beta-Catenin Signaling Pathway in Colon Cancer. DNA and Cell Biology. 41(12). 1075–1083. 4 indexed citations
11.
Wang, Qingsheng, Xiaomei Jiang, Xiaojing Ma, et al.. (2022). The efficacy and safety of acupuncture and nicotine replacement therapy for smoking cessation: study protocol for a randomized controlled trial. Trials. 23(1). 465–465. 2 indexed citations
12.
Wa, Qingde, Changye Zou, Zhuoyuan Lin, et al.. (2020). Ectopic Expression of miR-532-3p Suppresses Bone Metastasis of Prostate Cancer Cells via Inactivating NF-κB Signaling. Molecular Therapy — Oncolytics. 17. 267–277. 30 indexed citations
13.
Yu, Xiang, Dong Ren, Wei Feng, Qiong Han, & Die Hu. (2020). Breast cancer metastasis suppressor 1 gene enhances the sensitivity of osteosarcoma cells to paclitaxel. Zhonghua shiyan waike zazhi. 37(1). 115–117. 1 indexed citations
14.
Yang, Qing, Chuandong Lang, Zhengquan Wu, et al.. (2019). MAZ promotes prostate cancer bone metastasis through transcriptionally activating the KRas-dependent RalGEFs pathway. Journal of Experimental & Clinical Cancer Research. 38(1). 391–391. 54 indexed citations
15.
Liu, Aibin, Meigong Zhong, Jihong Wei, et al.. (2019). Silencing LGR6 Attenuates Stemness and Chemoresistance via Inhibiting Wnt/β-Catenin Signaling in Ovarian Cancer. Molecular Therapy — Oncolytics. 14. 94–106. 43 indexed citations
16.
Ren, Dong, et al.. (2018). MALAT1 induces osteosarcoma progression by targeting miR‐206/CDK9 axis. Journal of Cellular Physiology. 234(1). 950–957. 32 indexed citations
17.
Ren, Dong, Yuhu Dai, Qing Yang, et al.. (2018). Wnt5a induces and maintains prostate cancer cells dormancy in bone. The Journal of Experimental Medicine. 216(2). 428–449. 140 indexed citations
18.
Jiang, Chunlin, Miao Yu, Xiaoyan Xie, et al.. (2017). miR-217 targeting DKK1 promotes cancer stem cell properties via activation of the Wnt signaling pathway in hepatocellular carcinoma. Oncology Reports. 38(4). 2351–2359. 42 indexed citations
19.
Wang, Min, Dong Ren, Wei Guo, et al.. (2015). N-cadherin promotes epithelial-mesenchymal transition and cancer stem cell-like traits via ErbB signaling in prostate cancer cells. International Journal of Oncology. 48(2). 595–606. 114 indexed citations
20.
Wang, Min, Dong Ren, Wei Guo, et al.. (2014). Loss of miR-100 enhances migration, invasion, epithelialmesenchymal transition and stemness properties in prostate cancer cells through targeting Argonaute 2. International Journal of Oncology. 45(1). 362–372. 65 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Chuyong Lin Breakdown of academic impact, for papers by Paolo Gandellini Breakdown of academic impact, for papers by Altaf A. Dar Breakdown of academic impact, for papers by Yixuan Hou Breakdown of academic impact, for papers by Jongchan Kim Breakdown of academic impact, for papers by Aleksandra Franovic Breakdown of academic impact, for papers by Douglas S. Micalizzi Breakdown of academic impact, for papers by Bisrat G. Debeb Breakdown of academic impact, for papers by Zhengsheng Wu Breakdown of academic impact, for papers by Weijian Guo
Rankless by CCL
2026